Pharma Focus Asia

Innovus Pharma Expands International Distribution by Signing an Exclusive Agreement in Peru with Pharma Solutions

Monday, December 04, 2017

Innovus Pharmaceuticals, Inc., an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases, announced today the signing of an exclusive license and distribution agreement with Corporacion Pharma Solutions Peru SAC, a Peruvian company (“Pharma Solutions”) for the commercialization of Zestra®, Zestra Glide®, EjectDelay® and Sensum+® in Peru. As part of the agreement, Innovus Pharma will receive an upfront payment and minimum yearly quantity of orders.

The Company expects to ship its first commercial order to Peru within thirty (30) days of Pharma Solutions receiving regulatory approval from the Peru Health Authorities, which is currently expected to be Q1 2018.

“We are pleased to expand our global reach and commercialization market for four of our important men’s and women’s health products, which include Zestra®, Zestra Glide®, EjectDelay® and Sensum+® in Peru,” said Innovus Pharma CEO, Dr. Bassam Damaj. “Pharma Solutions is our 17th distribution partner for our products outside the United States and is our first distributor in South America, a region that we are looking forward to expanding into,” continued Dr. Damaj.

To date, Innovus Pharma has focused on expanding its worldwide footprint:

  • •  License and distributor agreements with 17 international distributors covering 112 countries worldwide;
  • •  The Company or its distributors have received approval from 37 countries to sell 6 of Innovus Pharma’s products in such countries - products include Zestra®, Zestra Glide®, Sensum+®, EjectDelay®, Vesele® and UriVarx®;
  • •  The Company has filed for approval for another 2 products: Xyralid® and ProstaGorx®; and
  • •  Innovus Pharma is currently generating revenue from the sale of its products by its distributors in 10 countries outside the U.S.
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Thermo Fisher Scientific - Rapid Mycoplasma TestingAsia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024Medlab Middle East 2024ISPE Singapore Affiliate Conference & Exhibition 2024